Autophagy is likely to be stimulated during AKI and repressed during CKD, and strategies to target downstream signaling pathways, such as NLRP3 inflammasome inhibition by pterostilbene to modulate autophagy could serve as novel therapeutic strategies to prevent the maladaptive repair in damaged renal cells during injury. This evidence concerns the gene NLRP3 and chronic kidney disease.